Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.11
▾0.005 (4.76%)
Last trade: 12/10, 3:56AM
Market cap
$32.15m
Market closed
Talk to Noxopharm Limited directly.
Sign up to their Investor Hub for direct access to the Noxopharm Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Noxopharm Limited (ASX:NOX) is a clinical-stage oncology drug development company. Noxopharm operates in the healthcare sector, specifically in the area of drug development. The Company has a primary focus on the development of Veyonda®, a clinical stage drug designed to enhance the effectiveness and safety of chemotherapy and radiotherapy.
Address
Suite 3, Level 4/828 Pacific Hwy, Gordon NSW 2072, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.11
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.